Lifecore Biomedical, Inc. (FRA:LDE)
Germany flag Germany · Delayed Price · Currency is EUR
6.55
+0.20 (3.15%)
At close: Dec 5, 2025

Lifecore Biomedical Company Description

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States.

The company engages in the manufacturing of hyaluronate acid (HA) in bulk form, as well as formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures.

Its product development services include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and production of materials for clinical studies.

The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022.

Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Lifecore Biomedical, Inc.
Country United States
Founded 1965
Industry Pharmaceutical Preparations
Employees 406
CEO Paul Josephs

Contact Details

Address:
3515 Lyman Boulevard
Chaska, Delaware 55318
United States
Phone 952 368 4300
Website lifecore.com

Stock Details

Ticker Symbol LDE
Exchange Frankfurt Stock Exchange
Stock Type Common Stock
Fiscal Year June - May
Reporting Currency USD
SIC Code 2834

Key Executives

Name Position
Paul Josephs Chief Executive Officer
Ryan Lake Chief Financial Officer
Thomas Guldager Chief Operating Officer